key: cord-0829398-jtrtv2xt authors: Pilotto, Andrea; Odolini, Silvia; Stefano Masciocchi, S; Comelli, Agnese; Volonghi, Irene; Gazzina, Stefano; Nocivelli, Sara; Pezzini, Alessandro; Focà, Emanuele; Caruso, Arnaldo; Leonardi, Matilde; Pasolini, Maria Pia; Roberto Gasparotti, R; Francesco Castelli, F; Ashton, Nicholas J.; Blennow, Kaj; Zetterberg, Henrik; Padovani, Alessandro title: Steroid‐responsive encephalitis in Covid‐19 disease date: 2020-05-17 journal: Ann Neurol DOI: 10.1002/ana.25783 sha: 0d2ef48a0b17f56cf8494fe49f0b6d9643c03a7b doc_id: 829398 cord_uid: jtrtv2xt Covid‐19 infection has the potential for targeting the central nervous system and several neurological symptoms have been described in patients with severe respiratory distress. Here we described the case of a 60‐year old subject with SARS‐CoV‐2 infection but only mild respiratory abnormalities who developed an akinetic mutism due to encephalitis. MRI was negative whereas EEG showed generalized theta slowing. CSF analyses during the acute stage were negative for SARS‐CoV‐2, positive for pleocytosis and hyperproteinorrachia, and showed increased IL‐8 and TNF‐α concentrations while other infectious or autoimmune disorders were excluded. A progressive clinical improvement along with a reduction of CSF parameters was observed after high‐dose steroid treatment, thus arguing for an inflammatory‐mediated brain involvement related to Covid‐19. This article is protected by copyright. All rights reserved. Covid-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by respiratory tract symptoms with possible severe outcome mostly related to pneumonia and severe acute respiratory distress syndrome (SARS) 1 . Data regarding specific neurological involvement due to SARS-CoV-2 infections are lacking. Neurological symptoms including headache and delirium have been described in epidemiological studies in up to 30% of patients 2 . Although previous coronavirus infections have been associated with involvement of the central nervous system (CNS) 3 , the neurotropism of Covid-19 is still under debate 4-6 . This article is protected by copyright. All rights reserved. The present report describes a case of encephalitis in a patient with Covid-19. During his hospitalization, he never developed SARS but had mild respiratory symptoms. The patient provided an informed written consent for the report and the diagnostic/therapeutic procedures were conducted in accordance with institutional and international guidelines for protection of human subjects. The study was approved by the local ethics committee of the ASST Spedali Civili di Brescia Hospital and the requirement for informed consent was waived by the Ethics Commission (NP 4051, approved 06.04.2020). An otherwise healthy 60-year-old man presented to the Emergency Department for a severe alteration of consciousness. According to the relatives, the symptoms started five days earlier with the development of progressive irritability, confusion and asthenia followed two days later by fever, cough and cognitive fluctuations. At admission, his vital parameters were within the normal ranges and his body temperature was 36.8 °C. Oxygen saturation was within normal limits with a slight reduction of the arterial partial pressure of oxygen (Sp02 73 mmHg). The patient showed a severe akinetic syndrome associated to mutism; he was uncooperative and unable to carry out even simple orders if not stimulated. A positive palmomental and glabella reflexes with moderate nuchal rigidity was detected with no focal signs at the neurological examination. This article is protected by copyright. All rights reserved. Blood analyses revealed normal blood cell counts, increased D-dimer (968 ng/mL) but normal levels of CRP, fibrinogen and ferritin. Chest x-ray showed moderate bilateral interstitial pneumonia. Based on the history, the radiological findings and the Covid-19 outbreak in the region, a real-time reverse transcriptase-polymerase chain reaction assays (RT-PCR) on nasopharyngeal swab was performed and confirmed a SARS-CoV-2 infection. Antiviral therapy with Lopinavir/Ritonavir 400/100 mg BID and hydroxychloroquine 200 mg BID was started. A brain CT scan was unremarkable, and the patient was hospitalized. At admission, a lumbar puncture was performed, and CSF showed inflammatory findings with mild lymphocytic pleocytosis (18/uL) and moderate increase of CSF protein (69.6 mg/dL). The analysis of neurotropic viruses (HSV-1, HSV-2, HSV-6, HSV-8, EBV, VZV, Adenovirus and Enterovirus) was negative. CSF RT-PCR for SARS-CoV-2 was also negative. An electroencephalography (EEG) exhibited generalized slowing with decreased reactivity to acoustic stimuli ( Figure 1 ). The same day an empirical treatment of ampicillin and acyclovir was introduced. The day after, the magnetic resonance imaging (MRI) with gadolinium contrast did not reveal any significant alterations or contrast-enhanced areas within the brain and/or meninges ( Figure 1 ). Three days after admission, given the persistence of clinical symptoms, high-dose intravenous steroid treatment was started (methylprednisolone 1 g/day for five days). CSF analyses, carried out one day after steroid administration, showed lymphocytic pleocytosis (18/uL), hyperproteinorrachia (127.2 mg/dL) and normal Link index without oligoclonal bands. CSF RT-PCR for SARS-CoV-2 was still negative. At this time, CSF analyses revealed relatively slightly increased levels of interleukin 6 (IL-6) of 2.36 pg/mL, strongly increased levels of interleukin 8 (IL-8, higher than 1100 pg/mL) and increased levels of tumor necrosis factor alpha (TNF-α, 1.31 pg/mL) and β2-microglobulin (β2M, 3.06 This article is protected by copyright. All rights reserved. Table 1 ). After the first infusion, the patient improved-He became alert and able to execute simple tasks on command and to repeat single words. The following days, the patient was able to talk and to answer simple questions. Once the five days-high dose steroid therapy ended, he displayed only mild disinhibition and somewhat fluctuating alertness. The potential neurotropism of SARS-CoV-2 with direct or autoimmune-mediated response is still debated 4-6,7 . We here described a case of steroid-responsive encephalopathy in a patient with confirmed SARS-CoV-2 infection. This article is protected by copyright. All rights reserved. After the first reports describing severe pneumonia cases in Wuhan, China, Covid-19 rapidly spread worldwide with critical challenges for the health care systems globally 8, 9 . The World Health Organization has thus declared Covid-19 a public health emergency of international concern, with more than 200,000 deaths on the 25 th of April. Brescia, situated in the Lombardy region, northern Italy, was one of the provinces most affected by Covid-19 accounting for more than 2100 deaths on the 25 th of April 2020. Epidemiological studies showed that Covid-19 presents in most cases with fever and upper respiratory symptoms 2 . Recently, the study performed by Mao and coauthors 6 reported neurological manifestations of Covid-19 in the outbreak in China in up to 36.4% of patients hospitalized, including alteration of consciousness, headache, dizziness and delirium 6 . Neurological manifestations were also reported in previous epidemiological studies on larger samples 2 . Neuroinfectivity has been described for other coronaviruses but is still questioned for SARS-CoV-2. observations of frequent and persistent anosmia/dysgeusia. Several authors reported neurological symptoms in severe cases, supporting the concept that CNS symptoms might be secondary to severe respiratory failure 7 . Another important aspect is the hyperinflammation state secondary to SARS-CoV-2 infection, with massive release of cytokines and chemokines that could alter the permeability of blood-brain barrier (BBB). This phenomenon could indeed cause the activation of the neuroinflammation cascade 5 . Hypothetically, SARS-CoV-2 could also induce, by molecular mimicry-related mechanisms, the This article is protected by copyright. All rights reserved. 12 . In our case, the blood brain barrier alterations supported by CSF analyses argue for a potential CNS invasion via blood route of COVID-19 3 . Of interest, peculiar akinetic mutism presentation has been associated with cases of Epstein-Barr encephalitis 13 . However, the normal MRI findings, with no meningeal enhancement or brain alterations, and the response to steroid treatment support other alternative pathophysiological mechanisms. In this case, we excluded the most common causes of autoimmune encephalitis, akinetic mutism and psychosis so far [14] [15] [16] . Another possible explanation of transitory akinetic mutism would be an abnormal neuroinflammation response induced by SARS-CoV-2 17, 18 , better fitting with the prompt response to steroid treatment. To support this hypothesis, we measured CSF levels of IL-6, IL-8, TNF-α and β2-microglobulin at two different time points. At the time of the akinetic mutism presentation, we observed pleocytosis and a severe increase of CSF inflammatory proteins, IL-8 in particular, but also TNF-α and β2microglobulin. After clinical improvement, the inflammatory biomarkers decreased, whilst β2-This article is protected by copyright. All rights reserved. microglobulin and CSF cell counts remained abnormal. This suggest a possible cytokine-mediated hyperinflammation response. The role of steroid treatment in the resolution of symptoms of the here-presented case, however, definitely need further observations to be confirmed. Indeed, a still unpublished work posted on pre-print described two cases of suspected encephalitis associated with Covid-19, in which the improvement was in a similar time frame treatment-independent 19 . Of interest, CSF cytokine alterations were not associated with severe abnormalities of peripheral markers of inflammation or severe respiratory involvement 19 , arguing for a CNS-specific abnormal inflammation response leading to neurological manifestation 20 . This fit with normal serial imaging and the absence of biomarker evidence of neuronal injury, suggesting a functional rather than a destructive neuronal network impairment. The case highlighted that Covid-19 may involve severe neurological alterations independently from respiratory function. Despite the lack of a clear pathophysiological mechanism, the apparently positive response to steroid treatment together with the normalization of CSF cytokines argues for the encephalitis in our patient to have been mediated by a hyperinflammatory mechanism. On the other hand, although there was no evidence of SARS-CoV-2 in the CSF by RT-PCR, a direct CNS infection cannot be excluded. This report suggests that it may be useful to investigate the therapeutic effects of corticosteroid administration in Covid-19 related encephalitis. This article is protected by copyright. All rights reserved. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical Characteristics of Coronavirus Disease 2019 in China Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study Sars-Cov-2: Underestimated damage to nervous system The Lancet Infectious Disease COVID-19 Can China's COVID-19 strategy work elsewhere? Two Cases of Late-Onset Anti-NMDAr Auto-Immune Encephalitis After Herpes Simplex Virus 1 Encephalitis A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium Infect Dis Akinetic mutism and status epilepticus due to Epstein Barr virus encephalitis Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin Neuronal surface antibody mediated autoimmune encephalitis HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression Cytokine release syndrome in severe COVID-19 Two patients with acute meningo-encephalitis concomitant to SARS-CoV2 infection medRxiv erebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients This article is protected by copyright. All rights reserved.We thank the patient for his participation in the study.